Novo Nordisk A/S

Description

Builds medicines and treatments for people with diabetes and obesity; used by patients, healthcare professionals, and researchers for disease management and study.

Related

• ALK-Abelló A/SDevelops allergy treatments and related solutions for people with respiratory allergies, serving healthcare providers and patients through…
• Max Planck Institute for Metabolism ResearchThe institute researches how the body regulates weight and glucose metabolism.
• Camurus ABDevelops innovative, long-acting treatments for severe and chronic diseases; used by patients and healthcare systems addressing unmet…
• Danish National Genome CenterDanish National Genome Center works to improve future treatment for patients in Denmark.
• LEO Pharma A/SLEO Pharma researches, develops, and delivers medicines for skin diseases.
• Sangamo Therapeutics ($SGMO)Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom…
• Esperion Therapeutics ($ESPR)Develops and commercializes medicines for cardiovascular disease, including cholesterol management, cardiovascular risk reduction, and…
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• Bavarian Nordic A/SBuilds vaccines for prevention and public health; used by travelers, healthcare providers and public health programs to protect against…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…